Roger Smith
Has open position
Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Positions (2)
University of Newcastle
University of Newcastle
Posted Yesterday
This PhD project at the University of Newcastle and Hunter Medical Research Institute will develop a precision nanomedicine approach for advanced thyroid cancer, particularly recurrent, metastatic and radioiodine-refractory disease. The research combines nucleic acid therapeutics—including siRNA, antisense oligonucleotides and microRNA-based approaches—with targeted lipid nanoparticles (LNPs). The candidate will investigate molecular vulnerabilities and apoptotic pathways in thyroid cancer cells, identify therapeutic targets, and evaluate nucleic acid treatments capable of selectively inducing cancer cell death. Promising therapeutics will be incorporated into targeted LNP formulations designed to deliver their cargo selectively to thyroid cancer cells. The project will examine particle size, stability, encapsulation efficiency, cellular uptake and therapeutic delivery, followed by studies of tumour targeting, biodistribution, efficacy and potential toxicity in preclinical models. The candidate will work in an established multidisciplinary research program with facilities for lipid nanoparticle manufacture and characterisation, molecular biology, cancer cell culture, flow cytometry, confocal and advanced microscopy, histology, tissue analysis and preclinical animal research. Training will span cancer biology, RNA and nucleic acid therapeutics, nanomedicine, targeted drug delivery and translational research. The project may support broader applications of targeted therapeutic nucleic acids in solid cancers and future translational or commercial development.
Posted Yesterday
Roger Smith
University of Newcastle
10 months ago
This PhD scholarship at the University of Newcastle offers an exciting opportunity for candidates with experience in targeting therapy in cancer to contribute to the development of novel approaches for the treatment of thyroid cancer. The successful applicant will work under the supervision of NHMRC fellow and Laureate Professor Roger Smith, in affiliation with the Hunter Medical Research Institute, a leading center for medical research in Australia. The project focuses on innovative cancer therapeutics, specifically targeting thyroid cancer, and aims to translate laboratory findings into clinical applications. Candidates will be involved in cutting-edge research, collaborating with experts in oncology and medical science, and will have access to state-of-the-art facilities and resources provided by the Hunter Medical Research Institute. The scholarship provides a generous living allowance of $38,938 per annum (2026 rate), indexed annually, and covers tuition fees for 3.5 years. Additionally, successful candidates may receive up to $1,500 as a relocation allowance. The award is contingent upon the full establishment of grant funding. Eligibility is restricted to domestic students who meet the minimum PhD admission criteria at the University of Newcastle. Applicants should demonstrate prior experience in cancer therapy targeting and must submit a comprehensive application package, including academic transcripts, CV, a statement of research interests, and a proposal that aligns with the research project. Applications must be submitted via email to [email protected] by 5pm on 11 January 2026. For further details and to review the scholarship information, candidates are encouraged to visit the official university scholarship page. This is a unique opportunity to advance your research career in medical science and contribute to impactful cancer research.
10 months ago
Make your next move.
Prepare your application
Review drafts before you send them.